Replimune Group, Inc. (REPL)
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.
Address
500 UNICORN PARK
WOBURN, MA 01801
Founded
2015
Number of Employees
331
Website
http://www.replimune.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at REPL make a trade.
Creating a free account takes less than one minute